Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 511.5B | 507.4B | 505.9B |
Cost of revenue | — | 378.6B | 366.9B | 361.7B |
Gross profit | — | 133.0B | 140.5B | 144.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 119.9B | 114.7B | 115.8B |
Other operating expenses | — | — | — | — |
Operating income | — | 13.1B | 25.8B | 28.3B |
Non operating interest income | ||||
Income | — | 3.1B | 27.3B | 3.1B |
Expense | — | 15.3B | 1.2B | 1.4B |
Other income expense | — | — | — | — |
Pretax income | — | 10.5B | 47.8B | 27.4B |
Tax provision | — | -1.5B | 13.0B | 7.4B |
Net income | — | 12.0B | 34.8B | 19.9B |
Basic EPS | 26.1 | — | 24.1 | 13.5 |
Diluted EPS | 26.1 | — | 24.1 | 13.5 |
Basic average shares | 1.4B | — | 1.4B | 1.4B |
Diluted average shares | 1.4B | — | 1.4B | 1.4B |
EBITDA | — | 67.2B | 89.1B | 67.7B |
Net income from continuing op. | — | 12.0B | 34.8B | 19.9B |
Minority interests | — | -1.3B | -899M | -854M |
Preferred stock dividends | — | 0 | 0 | 0 |